The Impact of DOGE Layoffs: A Heartrending Interview with an Epidemiologist Facing Job Loss

In a recent turn of events, the Trump administration has taken drastic measures to dismantle essential defenses against HIV, causing immense worry among public health experts. Following the termination of critical programs such as the Adolescent Trials Network (ATN) and significant layoffs at the Centers for Disease Control and Prevention (CDC), the ripple effects have been felt by many—including dedicated professionals like epidemiologist Tara Kerin.

The ATN, established in 2001, has been instrumental in HIV research, enrolling over 30,000 individuals in more than 150 studies. Its cancellation not only halts advancements in HIV prevention but also shuts down research focusing on adolescents and young adults, a demographic that has historically lacked sufficient attention in HIV studies. This abrupt termination aligns with language in cancellation notices reflecting a disconcerting trend to disregard diversity, equity, and inclusion in scientific research.

Dr. Kerin was actively engaged in a groundbreaking research project targeting the use of doxycycline as a preventive measure for sexually transmitted infections (STIs). This strategy, known as doxycycline post-exposure prophylaxis (doxyPEP), has shown promise in significantly reducing infections among certain populations. Despite the encouraging evidence, the CDC has yet to provide recommendations for other demographics, including young women, leaving a critical gap in STI prevention strategies.

"I'm devastated," Kerin shared when discussing the cancellation of her study on doxyPEP for adolescent and young cis women. She emphasized, "Women are typically underrepresented in research studies. This project could have empowered women to take control of their sexual health, but now it won’t see the light of day."

The end of this funding means that Kerin, who has relied on ATN grants for her livelihood since 2017, is now facing unemployment. "I was on track to work for the next four years on this project. With this cancellation, my future is uncertain, just like many other scientists who depend on federal grants for their work."

The urgency of maintaining funding for public health research cannot be overstated, especially when it comes to combating infectious diseases. Kerin voiced her fears about the global implications of cutting HIV funding, stating, "It's not just about individual grants; it's about the broader impact on public health. If we cut HIV treatments and preventative measures, we risk cultivating drug-resistant strains of the virus—and that could lead to a public health crisis of unprecedented proportions."

Reflecting on her journey, Kerin mentioned how early experiences in the CDC's rotavirus lab sparked her passion for public health. Acknowledging the importance of a global approach to disease control, she emphasized that local health is intricately connected to global health. "You can’t eradicate a disease in isolation. The world is interconnected, and neglecting one area can have devastating consequences elsewhere."

As a determined advocate for comprehensive health solutions, Kerin called for renewed focus on funding and supporting research that addresses the health needs of diverse populations. "The dismantling of these programs is not just a setback; it's a step back for years of progress in public health."

In closing, she urged the public and policymakers to prioritize funding for healthcare research, not only for the sake of advancement in medical science but to ensure that future generations have the means to protect their health. The cancellation of critical studies like hers is more than a personal blow—it's a lost opportunity for an entire generation to gain agency over their health in the sexual landscape.

The conversation surrounding public health funding needs to evolve, remaining cognizant of the global context in which these health issues exist. As we continue to face waves of infectious diseases, the call for investment in science and equitable healthcare solutions has never been more crucial.